Literature DB >> 16287732

Facilitated percutaneous coronary intervention.

B R Brodie1.   

Abstract

Mesh：

Year:  2005        PMID： 16287732      PMCID： PMC1769241          DOI： 10.1136/hrt.2005.064618

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  15 in total

1.  A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.

Authors:  A M Ross; K S Coyne; J S Reiner; S W Greenhouse; C Fink; A Frey; E Moreyra; M Traboulsi; N Racine; A L Riba; M A Thompson; S Rohrbeck; C F Lundergan
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

2.  Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study.

Authors:  F Vermeer; A J Oude Ophuis; E J vd Berg; L G Brunninkhuis; C J Werter; A G Boehmer; A H Lousberg; W R Dassen; F W Bär
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

3.  Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study.

Authors:  P Widimský; L Groch; M Zelízko; M Aschermann; F Bednár; H Suryapranata
Journal:  Eur Heart J       Date:  2000-05       Impact factor: 29.983

4.  Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials.

Authors:  G W Stone; D Cox; E Garcia; B R Brodie; M C Morice; J Griffin; L Mattos; A J Lansky; W W O'Neill; C L Grines
Journal:  Circulation       Date:  2001-08-07       Impact factor: 29.690

5.  Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

Authors:  E J Topol
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

6.  Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction.

Authors:  B R Brodie; T D Stuckey; C Hansen; D Muncy
Journal:  Am J Cardiol       Date:  2000-01-01       Impact factor: 2.778

7.  Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis.

Authors:  Gilles Montalescot; Maria Borentain; Laurent Payot; Jean Philippe Collet; Daniel Thomas
Journal:  JAMA       Date:  2004-07-21       Impact factor: 56.272

8.  Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2.

Authors:  P Widimský; T Budesínský; D Vorác; L Groch; M Zelízko; M Aschermann; M Branny; J St'ásek; P Formánek
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

9.  A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction.

Authors:  W W O'Neill; R Weintraub; C L Grines; T B Meany; B R Brodie; H Z Friedman; R G Ramos; V Gangadharan; R N Levin; N Choksi
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

Review 10.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321
View more
  1 in total

Review 1.  Recent advances in primary percutaneous intervention for acute myocardial infarction.

Authors:  E J Smith; A Mathur; M T Rothman
Journal:  Heart       Date:  2005-12       Impact factor: 5.994
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.